Catalyst

Slingshot members are tracking this event:

Phase 2b topline data of Emricasan fo Liver fibrosis post orthotopic liver trasplant due to Hepatitis C virus infection (HCV-POLT) due 1H 2018

Source Link:
http://ir.conatuspharma.com/releasedetail.cfm?ReleaseID=940644

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CNAT Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 04, 2018
Occurred Source:
http://ir.conatuspharma.com/news-releases/news-release-details/conatus-pharmaceuticals-announces-top-line-results-phase-2b-polt
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2b Topline Data, Emricasan, Liver Fibrosis, Post Orthotopic Liver Transplant, Hepatitis C
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.